期刊文献+

(N-[^(18)F]氟甲基)胆碱的半自动合成和无菌型炎症PET显像评价 被引量:3

Semi-automatic Synthesis and PET Imaging Evaluation of ^(18)F-fluoromethylcholine With the Aseptic Inflammation Model
下载PDF
导出
摘要 通过对现有的合成模块进行改进,实现了(N-[18F]氟甲基)胆碱(18F-FCH)的半自动合成,并用其进行了无菌型炎症PET显像。以CH2Br2为前体,经过氟化反应制备甲基化试剂18FCH2Br,在柱与N,N-二甲基乙醇胺进行反应,并经过Sep Pak tC18和Sep Pak CM小柱联用纯化的方法,得到放化纯度大于95%的18F-FCH注射液,放化产率为12%±2%(n=3,按18F-计算,未校正),放化合成时间为35min。PET显像表明,肌肉注射0.2mL松节油,4天后形成的炎症模型具有18F-FDG最高摄取,而18F-FCH在炎症处具有轻度的放射性浓聚,因此在18F-FCH肿瘤显像时应考虑炎症的可能性。 Semi-automated synthesis of ^18F-fluoromethylcholine (18 F-FCH) was achieved with the modification of the commercial synthesis model and the PET imaging of aseptic inflammation model was performed with^18F-FCH. ^18FCH2Br as a [^188 F] fluoromethylation agent was prepared by the fluorination of dibromomethane followed by distillation from the reaction vessel. The obtained IS FCHzBr then reacted with N, N-dimethylamino ethanol loaded on the Sep Pak tC18 cartridge to give ^18F-FCH. After being purified on the solidphase extraction cartridges, ^18F-FCH was obtained with 12 %± 2 % radiochemieal yields (n =3, decay not corrected), and higher than 95% radiochemical purity. The synthesis time was less than 35 min. PET imaging showed that ^18F-FCH had a slightly lower uptake than ^18F-FDG in the inflammation tissues infected with turpentine oil, suggesting a potential use of ^18F-FCt-I to differentiate between a tumor and inflammation by PET imaging.
出处 《同位素》 CAS 2011年第4期198-204,共7页 Journal of Isotopes
基金 国家高科技计划(863计划)专题课题(2008AA02Z430) 国际原子能机构资助项目(15245/RO)
关键词 [18F]氟甲基胆碱 炎症 18F-FDG PET显像 ^18F-fluoromethylcholine (^18F-FCH) inflammation ^18F-FDG PET imaging
  • 相关文献

参考文献19

  • 1Toshihiko Hara. ^11C-Choline and 2-deoxy-2-[^18F] fuoro-D-glucose in tumor imaging with positron e-mission tomography [J ]. Molecular Imaging and Biology, 2002, 4: 267-273.
  • 2Toshihiko Hara, Noboru Kosaka, Nobusada Shi- noura, et al. PET imaging of brain tumor with [methyl-^11C]choline[J]. The Journal of Nuclear Medicine, 1997, 38: 842-847.
  • 3Toshihiko Hara, Noboru Kosaka, Hiroichi Kishi. PET imaging of prostate cancer using carbon-11- choline [J]. The Journal of Nuclear Medicine, 1998, 39:990-995.
  • 4Mitsuyoshi Yoshimoto, Atsuo Waki, Atsushi Ob- ata, et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate[J]. Nuclear Medicine and Biology, 2004, 31: 859-865.
  • 5Schmid DT, Hubert John, Roland Zweifel, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience [J]. Radiology, 2005, 235:623-628.
  • 6DeGrado RT, Coleman RE, Wang Shuyan, et al. Synthesis and evaluation of ^18 F-labeled choline as an oncologic tracer for positron emission tomo- graphy; initial findings in prostate cancer[J].Cancer Research, 2001, 61: 110-117.
  • 7Wyss MT, Bruno Weber, Michael Honer, et al. ^18 F-choline in experimental soft tissue infection as- sessed with autoradiography and high-resolution PET[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31: 312-316.
  • 8Nicolas Spaeth, Matthias T, Wyss Bruno Weber, et at. Uptake of ^18 F-fluorocholine, ^18 F-fluoroethyl-L-tyrosine, and ^18F-FDG in acute cerebral radia- tion injury in the rat: implications for separation of radiation necrosis from tumor recurrence[J]. The Journal of Nuclear Medicine, 2004, 45: 1 931- 1 938.
  • 9Kazuo Kubota, Shozo Furumoto, Ren Iwata, et al. Comparison of ^18F-fluoromethylcholine and 2- deoxy-D-glucose in the distribution of tumor and inflammation [ J ]. Annals of Nuclear Medicine, 2006, 20(8): 527-533.
  • 10Xia Shao, Hockley BG, Raphael Hoareau, et al. Fully automated preparation of [^11 C] choline and [^18 F]fluoromethylcholine using TracerLab synthe- sis modules and facilitated quality control using an- alytical HPLC[J]. Applied Radiation and Iso- topes, 2011, 69(2): 403-409.

二级参考文献7

  • 1Hara T, Kosaka N, Kondo T, et al. Imaging of Brain Tumor, Lung Cancer, Esohagus Cancer, Colon Cancer, and Bladder Cancer With [C-11]Choline[J]. J Nucl Med, 1997,38(suppl):250.
  • 2Hara T. 18F-Fluorocholine:a New Oncologic PET Tracer[J]. J Nucl Med,2001,42(12):1 815-1 817.
  • 3Hara T, Kosaka N, Shinoura N, et al.PET Imaging of Brain Tumor With [methyl-11C]Choline[J]. J Nucl Med,1997,38(6):842-847.
  • 4Hara T, Yuasa M. Automated Synthesis of Fluorine-18 Labeled Choline Analogue:2-Fluoroethyl-dimethyl-2-oxyethylammonium[J]. J Nucl Med,1997,38(suppl):44.
  • 5Hara T, Kosaka N, Kishi H. Development of 18F-Fluoroethylcholine for Cancer Imaging With PET: Synthesis, Biochemistry, and Prostate Cancer Imaging[J]. J Nucl Med,2002,43(1):187-199.
  • 6Degrado T R, Coleman R E, Wang S, et al. Synthesis and Evaluation of 18F-Labeled Choline as an Oncologic Tracer for Positron Emission Tomography: Initial Findings in Prostate Cancer[J]. Cancer Res,2001,61(1):110-117.
  • 7Degrado T R, Baldwin S W, Wang S, et al. Synthesis and Evaluation of 18F-Labeled Choline Analogs as Onclogic PET Tracers[J]. J Nucl Med, 2001,42(12):1 805-1 814.

共引文献5

同被引文献36

  • 1郭喆,张锦明.^(11)C-胆碱在PET肿瘤显像中的应用[J].同位素,2005,18(3):178-182. 被引量:6
  • 2吴战宏,王世真,周前,傅喆,邱飞婵,霍力.^(18)F标记氟甲基胆碱的半自动合成及其生物分布[J].核化学与放射化学,2005,27(3):185-189. 被引量:6
  • 3张锦明,田嘉禾,王武尚,刘伯里.在线制备^(11)C-Triflate-CH_3[J].同位素,2006,19(2):124-128. 被引量:21
  • 4Zhu A, Shim H. Current molecular imaging pos-itron emitting radiotracers in oncology[J]. Nucl Med Mol Imaging, 2011, 45(1): 1-14.
  • 5DeGrado T R, Baldwin S W, Wang S, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers [J]. J Nucl Med, 2001, 42:1 805-1 814.
  • 6Hara T, Kondo T, Hara T, et al. Use of 18F- choline and n C-choline as contrast agents in posi- tron emission tomography imaging-guided ster- eotactic biopsy sampling of gliomas[J]. J Neu- ros, 2003, 99: 474-479.
  • 7Bauman G, Belhocine T, Kovacs M, et al. 18F- fluorocholine or prostate cancer imaging: A sys- tematic review of the literature[J]. Prostate Cancer Prostatic Dis, 2012, 15: 45-55.
  • 8Spaeth N, Wyss M T, Weber B, et al. Uptake of 18F_fluorocholine, 18F_fluoroethyl_L_tyrosine and is F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence[J]. J Nucl Med, 2004, 45.. 1 931-1 938.
  • 9Shao X, Hockley B G, Hoareau R. Fully auto- mated preparation of [11C]choline and [18 F] flu- oromethylcholine using Tracer Lab synthesis modules and facilitated quality control using ana- lytical HPLCEJ]. Appl Radiat Isot, 2011, 69 (2) .. 403-409.
  • 10Schmaljohann J, Sehirrmacher E, W/ingler B. Fully automated SPE-based synthesis and purifi- cation of 2-[18 F~ fluoroethyl-choline for human use[J3. Nuel Med Biol, 2011, 8(2) : 165-170.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部